Value of PSA measured in middle age in predicting diagnosis of advanced prostate cancer in an unscreened population No significant financial relationships to disclose. This is an ASCO Meeting Abstract ...

PSA density (PSAD) predicts pathologic upstaging following radical prostatectomy (RP) for prostate cancer, a study found. The finding suggests that PSAD may be an additional parameter that clinicians ...

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

The REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard NHS tests. Of the 29 ...

Using MRI scans in screening for prostate cancer could detect tumours missed by prostate-specific antigen (PSA) blood testing alone, according to a major new study from University College London (UCL) ...

Health care expert and lived experience panels came to a consensus on several aspects that should be considered in the decision to offer and continue active surveillance for prostate cancer. In ...

MRI screening shows promise for predicting clinically significant prostate cancer (PCa) early on and independently of prostate-specific antigen (PSA) assessment. In a recent study published in BMJ ...

The European Society for Medical Oncology has updated its clinical practice guidelines for the management of localised prostate cancer and biochemical recurrence, refining diagnostic pathways and ...